Federal Agricultural Mortgage Corporation Common Stock Stock (NYSE: AGM/A)

Latest News for Federal Agricultural Mortgage Corporation Common Stock Stock (NYSE:AGM/A)

Federal Agricultural

Federal Agricultural Mortgage Corporation Common Stock

Federal Agricultural Mortgage Corp

The Ohio Hemp Company has formalized a partnership with Heartland Industries, based in <a href="https://www.benzinga.com/topic/michigan-cannabis">Michigan</a>, to cultivate hemp fiber destined for the burgeoning bioplastics market.
This collaboration represents a significant stride towards <a href="https://www.benzinga.com/markets/cannabis/24/04/38341776/hemp-space-grew-3x-the-rate-of-cannabis-where-did-marijuana-get-it-wrong">sustainable manufacturing</a>&nbsp;with the hemp fiber being utilized in the production of automotive parts by a Belgian company.
<h3>Legislative Backing And Entrepreneurial Vision</h3>
This venture is buoyed by the legal landscape, with<a href="https://www.benzinga.com/topic/ohio-cannabis"> Ohio</a>&nbsp;Governor Mike DeWine&nbsp;(R) having signed legislation in 2019 that legalized hemp cultivation in the state. High Times <a href="https://hightimes.com/environment/ohio-company-signs-deal-to-grow-hemp-for-bioplastic/">reported</a> that TJ Richardson and Justin Helt, owners of the Ohio Hemp Company, were pioneers in this new agricultural frontier, initially focusing on the CBD market before shifting their attention to the potential of hemp for grain and fiber.
<h3>Innovation And Sustainability At The Forefront</h3>
The collaboration with Heartland Industries highlights the adaptability and vision of Ohio <a href="https://www.benzinga.com/topic/hemp">Hemp</a> Company. Heartland, having faced the challenges of reviving hemp cultivation, now works with multiple farmers across the Midwest to produce nurdles, a key component in the manufacture of bioplastics.
This innovative material, which integrates hemp fiber into traditional plastic, promises to reduce environmental impact without sacrificing quality or performance.
<h3>Expansion And Future Prospects</h3>
The agreement with Heartland Industries propels Ohio Hemp Company to new heights, setting the stage for the expansion of its<a href="https://www.benzinga.com/markets/cannabis/24/04/38327403/usda-hemp-market-report-shows-stability-and-growth-amid-challenges"> hemp cultivation</a> to 200 acres of <a href="https://www.benzinga.com/markets/cannabis/24/04/38210629/u-s-hemp-authority-announces-quality-seal-certification-for-delta-8-thc">dual-purpose hemp</a>.
This growth mirrors the broader movement within the ancillary cannabis business space, where established players from various sectors are seizing the opportunity to cement their presence.
<h3>Hemp Bioplastics For Packaging: A Multi-Billion Dollar Industry</h3>
Notably, the entry of heavyweight <a href="https://www.benzinga.com/markets/cannabis/20/02/15230155/disrupting-cannabis-packaging-when-big-packaging-companies-hemp-bioplastics-enter-the-space">packaging companies into the cannabis space </a>signals a transformative phase for the industry, where the intersection of sustainability and innovation becomes paramount.
<a href="https://www.benzinga.com/topic/casa-verde-capital">Casa Verde Capital</a>, led by <a href="https://www.benzinga.com/markets/cannabis/23/11/35918817/snoop-dogg-did-not-give-up-smoke-rapper-explains-publicity-stunt">Snoop Dogg</a>, exemplifies the strategic investment in ancillary cannabis businesses, highlighting the sector&#39;s potential.
With the global cannabis packaging market projected to reach $20 billion by 2025, the synergy between <a href="https://www.benzinga.com/topic/hemp">hemp </a>bioplastics and traditional packaging solutions opens up unprecedented opportunities for sustainable practices.
Photo: AI-Generated Image.&nbsp;

Biotech

Cannabis

News

Emerging Markets

Commodities

Markets

General

Ohio Hemp Company Re-Greening The Rust Belt With Bioplastics Option For Midwest Auto Industry

Efforts to secure financial relief for New York&#39;s 289 licensed cannabis farmers have stalled, leaving them disheartened and facing significant financial losses due to the 2024 state budget excluding the proposed Cannabis Farmer&rsquo;s Relief Fund, despite limited retail outlets exacerbating their situation.
<h3>Legislative Efforts Stalled</h3>
Despite the advocacy of Assemblywoman Donna Lupardo and Sen. Michelle Hinchey, the 2024 state budget will not include the proposed <a href="https://www.newyorkupstate.com/cannabis-insider/2024/04/new-yorks-cannabis-farmers-disheartened-over-lack-of-financial-relief-in-state-budget.html">Cannabis Farmer&rsquo;s Relief Fund</a>.
This decision leaves many farmers grappling with significant financial losses, a situation exacerbated by the limited number of retail outlets available for selling their products in 2022 and 2023.
Lupardo and Hinchey, who have been at the forefront of pushing for the relief package, expressed their disappointment over the inability to secure the necessary funds.
Their proposed package, which sought to offer $128 million in aid through grants, loans, and tax credits, garnered no support&nbsp;during budget discussions.
<h3>Market Misfortunes</h3>
The backdrop of this struggle is a <a href="https://www.benzinga.com/topic/new-york-cannabis">market</a> flooded with unsold cannabis, stemming from an <a href="https://www.benzinga.com/markets/cannabis/24/02/36898313/new-yorks-weed-virginias-alcohol-kentuckys-gop-hawaii-florida">oversupply and insufficient retail</a> avenues to distribute the product. New York&#39;s legal cannabis sector, expected to be among the nation&rsquo;s largest, has instead been marked by frustration and financial hardship.
Farmers have cultivated vast quantities of cannabis, <a href="https://www.benzinga.com/markets/cannabis/24/02/36954941/what-a-waste-new-york-cannabis-farmers-may-dump-125-tons-of-weed-due-to-scarcity-of-retail-shops">enough to supply</a> 1,500 stores, yet face a reality of barely 50 legal dispensaries open for business. This mismatch has left approximately 250,000 pounds of cannabis unsold, representing a critical loss in revenue and potential tax income for the state.
<h3>Substantial Revenue And Struggling Farmers</h3>
The absence of financial relief in the state budget not only underscores the ongoing challenges faced by <a href="https://www.benzinga.com/topic/new-york-cannabis">New York&rsquo;s cannabis industry </a>but also raises concerns about the future viability of these farming operations.
As the state anticipates substantial revenues from the cannabis sector, the reality on the ground for farmers paints a grim picture of struggling to manage unsold stock while seeking support.
Photo: AI-Generated Image.&nbsp;

Regulations

Small Business

Struggling New York Cannabis Farmers Excluded From State Budget, Relief Fund Is Dismissed

NBA veterans Udonis Haslem and Carmelo Anthony recently announced their entry into the <a href="https://www.benzinga.com/cannabis">cannabis industry</a>. With their respective launches, they aim to move into the industry by blending sports fame and cannabis entrepreneurship.
<h3 class="wp-block-heading">Haslem Unveils &#8216;FORTY OG&#8217; With The Flowery</h3>
Haslem, the Miami Heat legend, introduced &#8220;&#8216;FORTY OG,&#8221; a cannabis strain developed in collaboration with The Flowery, a Florida <a href="https://www.benzinga.com/markets/cannabis/24/01/36788857/staten-island-flowery-direct-to-consumer-legal-cannabis-ny" target="_blank" rel="noreferrer noopener">cannabis producer</a>. This launch, aligning with the 4/20 cannabis holiday, symbolizes Haslem&#8217;s deep connection to Miami and his commitment to high-quality cannabis. This collaboration extends beyond mere business, with Haslem actively participating in the company&#8217;s operations, embodying his &#8220;Keep Applying Pressure&#8221; mantra.
&#8220;I&#8217;m proud to be part of The Flowery family and to contribute to the cannabis community in Florida. Together, we&#8217;re setting new standards for quality and authenticity, and I&#8217;m excited to see what the future holds,&#8221; said Haslem in a press release.
Read also: <a href="https://www.benzinga.com/markets/cannabis/24/04/38299011/its-on-the-ballot-the-future-of-adult-use-cannabis-in-florida-whats-the-contingency-plan-if-lega" target="_blank" rel="noreferrer noopener">It&#8217;s On The Ballot! The Future Of Adult-Use Cannabis In Florida, What&#8217;s The Contingency Plan If Legalization Fails? &#8211; Benzinga</a>
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/22155707/Forty_OG-1024x683.png" alt="" class="wp-image-303047" style="width:532px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/22155707/Forty_OG-1024x683.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/22155707/Forty_OG-300x200.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/22155707/Forty_OG-768x512.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/22155707/Forty_OG-1536x1024.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/22155707/Forty_OG.png 1620w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">FORTY OG &#x7C; Source: The Flowery</figcaption></figure>
<h3 class="wp-block-heading">Anthony Launches Grand National</h3>
Concurrently, NBA icon Carmelo Anthony <a href="https://www.grandnationalagency.com/" target="_blank" rel="noreferrer noopener">announced</a> the launch of Grand National, a cannabis brand and agency co-founded with industry notables Jesce Horton and Brandon Drew Jordan Pierce. Grand National aims to empower cannabis companies through strategic brand development and market expansion. Moreover, the agency&#8217;s first <a href="https://www.stayme7ocannabis.com/" target="_blank" rel="noreferrer noopener">launch</a>, STAYME7O Cannabis, epitomizes Anthony&#8217;s vision of providing premium cannabis products that support mindfulness and well-being.
"Over the years, I was studying it, paying attention to the industry, seeing where it was going, the trajectory, taking in the feedback. Given all the research, why not do it? Talk about the benefits of cannabis, what to consume, how to consume," Anthony <a href="https://www.forbes.com/sites/lindseybartlett/2024/04/19/nba-legend-carmelo-anthony-launches-cannabis-brand-and-agency/?sh=4a5ca8545fac" target="_blank" rel="noreferrer noopener">told</a> Forbes. Both Anthony and his partners are committed to fostering diversity and inclusion within the industry, reflecting a shared vision of empowerment and innovation.
<figure class="wp-block-embed is-type-video is-provider-vimeo wp-block-embed-vimeo wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Melo X Lowd_HERO_Future Ending" src="https://player.vimeo.com/video/937024371?dnt=1&amp;app_id=122963" width="500" height="281" frameborder="0" allow="autoplay; fullscreen; picture-in-picture; clipboard-write"></iframe>
</div>
<figcaption class="wp-element-caption">Carmelo &#x7C; Source: STAYME7O</figcaption></figure>
<h3 class="wp-block-heading">Empowerment And Advocacy At The Heart Of New Ventures</h3>
As Haslem and Anthony venture beyond the basketball court into the <a href="https://www.benzinga.com/cannabis" target="_blank" rel="noreferrer noopener">cannabis industry</a>, the launches of FORTY OG and Grand National stand out for combining the influence of sports celebrities, entrepreneurial spirit and commitment to community advocacy.
Images courtesy of The Flowery and Grand National.

NBA Legends Carmelo Anthony, Udonis Haslem Ignite Cannabis Industry With New Ventures, Launching Exclusive Agency And Strain

Leading electric vehicle company Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) reports first-quarter financial results after market close <a href="https://www.benzinga.com/calendars/earnings">Tuesday, April 23.</a>
Here are the key earnings estimates, what analysts are saying and key items to watch.
Earnings Estimates: Analysts expect Tesla to report first-quarter revenue of $22.34 billion, according to data <a href="https://www.benzinga.com/pro/feature/newsfeed?gspk=bHVrZWphY29iaTUzNDg&amp;gsxid=tdEE0VrK8Jeg&amp;ref=lukejacobi5348">from Benzinga Pro.</a> The company reported revenue of $23.33 billion in last year's first quarter.
Tesla has beaten revenue estimates from analysts in three of the last five quarters.
Analysts expect Tesla to report earnings per share of 51 cents in the first quarter, compared to 85 cents reported in last year's first quarter. Over the past five quarters, Tesla beat analysts' earnings per share two times, missed two times and was even one time.
Tesla missed revenue and earnings per share estimates in the past two quarters compared to estimates from analysts.
In its fourth-quarter financial results, the company said it was between growth waves.
"In 2024, our vehicle growth rate may be notably lower than the growth rate achieved in 2023," the company said.
Related Link: <a href="https://www.benzinga.com/news/earnings/24/01/36768363/tesla-q4-earnings-highlights-revenue-miss-eps-miss-model-y-a-global-bestseller-next-gen-vehicle-upd">Tesla Q4 Earnings Highlights: Revenue Miss, EPS Miss, Model Y A Global Bestseller, Next-Gen Vehicle Update And More</a>
What Analysts Are Saying: Tesla had several well-known issues that would factor into the first quarter earnings results, Bank of America analyst John Murphy said in a new investor note.
"TSLA stock has been under material pressure due to both weaker EV fundamentals and sentiment around the electrification theme," Murphy said.
The analyst had a Neutral rating and price target of $220 on Tesla.
Murphy said the focus from investors would be on demand and future growth plans from Tesla.
"Despite near-term pressures, the unveiling of future growth drivers has the potential to support the stock."
Growth items from Murphy included Robotaxis and Model 2, which he said could be enough to support the stock. The analyst didn't expect any key announcements on Tuesday as management doesn't like to mix financial results with product unveilings.
"However, we believe the company may provide some hints on the Robotaxi event currently scheduled for August 8 and may also reiterate its intention to launch the Model 2 in 2025/2026."
Murphy said the new flows for Tesla weighed on the stock and had investors worried about the "growth implications for what is viewed to be a ‘growth' stock."
Wedbush analyst Daniel Ives recently said the first quarter conference call and commentary could have a huge impact on the stock as the "moment of truth" for Tesla and CEO Elon Musk.
Ives, who has an Outperform rating and price target of $300 said Tesla<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38336261/tesla-musk-face-moment-of-truth-with-q1-earnings-call-believers-are-giving-up-on-th"> faced difficult times</a> in the past, naming the 2015, 2018 and 2020 years as examples. Without a new strategy outlook on Tuesday's conference call, Ives sees "darker days" for Tesla's stock ahead.
"Next week's conference call and messaging one of the most important moments in the company's history in our view," Ives previously said.
Here are other recent<a href="https://www.benzinga.com/quote/TSLA/analyst-ratings"> analyst ratings for Tesla stock</a> and their price targets.
Piper Sandler: Overweight rating, $205 price target
Deutsche Bank: Downgrade from Hold to Buy, lowered price target from $189 to $123
Baird: Outperform rating, $280 price target
Barclays: Equal-Weight rating, lowered price target from $225 to $180
Wells Fargo: Underweight rating, lowered price target from $125 to $120
Citigroup: Neutral rating, lowered price target from $196 to $180
Key Items to Watch: Demand will be a key in the first quarter earnings results as the company recently announced <a href="https://www.benzinga.com/news/24/04/38357129/whats-going-on-with-tesla-stock-monday">additional price cuts.</a>
<a href="https://www.benzinga.com/markets/equities/24/04/38047077/tesla-stock-dives-as-q1-deliveries-disappoint-but-ev-giant-reclaims-top-spot-from-chinese-rival">First-quarter deliveries </a>and production of 386,810 units and 433,371 units, respectively, were declines on year-over-year and quarter-over-quarter basis. The figures were also below estimates from analysts.
Recent reports suggested Tesla was pausing its Model 2 next-gen vehicle launch. While Musk called the reports false, there was not a current timeline update on when the vehicle would be launched. Investors will be looking for a confirmation that the vehicle was coming soon and had not been pushed back.
The company previously said after its fourth-quarter financial results that it was "focused on bringing the next-generation platform to market as quickly as we can."
Investors will also be looking for a hint at what an August robotaxi news update could look like and if Tesla was ready to share more on its artificial intelligence initiatives.
With the Cybertruck not broken out individually yet in quarterly sales reports, investors were also keen to know how the vehicle was selling and where reservations lie after millions were previously reserved ahead of the launch.
Recent layoffs <a href="https://www.benzinga.com/news/24/04/38361822/tesla-layoffs-hit-marketing-team-retracts-advertising-push">by the company</a> could also be a topic of concern from investors and an area addressed by the company in the quarterly comments.
TSLA Price Action: Tesla stock closed down 3.40% to $142.05 on Monday, which came as shares hit new 52-week lows of $138.80 during the intraday session. Tesla shares are down 18.6% over the past year and down 43.6% year-to-date in 2024.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38188230/tesla-stock-faces-challenges-in-2024-2025-analyst-highlights-this-key-future-item-w">Tesla Stock Faces Challenges In 2024, 2025: Analyst Highlights This Key Future Item, &#8216;We Still Think TSLA Warrants A Place In Clients&#8217; Portfolios&#8217;</a>
Photo: Shutterstock

Analyst Color

Price Target

Previews

Reiteration

Analyst Ratings

Trading Ideas

TSLA

Tesla Q1 Earnings Preview: Is EV Giant No Longer A 'Growth Stock?' Analysts Cautious, Want Answers About Robotaxis, Model 2

Jason Taylor, a former executive at Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), is joining Microsoft Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) AI supercomputing team, according to a LinkedIn post by <a href="https://www.benzinga.com/general/24/04/38354903/microsoft-ceo-satya-nadella-says-openai-wouldnt-have-existed-without-microsofts-support">Microsoft Chief Technology Officer Kevin Scott. </a>
&#8220;I'm super excited to welcome Jason Taylor to Microsoft, who starts today reporting to me as CVP [corporate vice president] &amp; Deputy CTO for our AI supercomputing efforts,&#8221; Scott wrote.
See Also: <a href="https://www.benzinga.com/general/gaming/24/04/38364762/microsoft-meta-reveal-limited-edition-meta-quest-vr-headset-with-game-pass-bundle">Microsoft, Meta Reveal Limited Edition Meta Quest VR Headset With Game Pass Bundle</a>
As <a href="https://www.theverge.com/2024/4/22/24137391/microsoft-hires-meta-ai-supercomputing-jason-taylor">reported</a> by The Verge, Taylor held various roles at Meta, including vice president of infrastructure, where he oversaw AI, data and privacy infrastructure, as well as managed server budgets.
He also chaired the Open Compute Project Foundation from 2015 to 2017, promoting open-source designs in data centers.
Microsoft and OpenAI are striving to enhance their hardware capabilities to keep pace with the rapid advancements in AI technology. 
Recent reports suggested plans to construct a $100 billion supercomputer named &#8220;Stargate,&#8221; although Scott appears to downplay these rumors in his LinkedIn post, labeling much of the speculation as &#8220;amusingly wrong.&#8221;
This move follows Microsoft&#8217;s hiring of Mustafa Suleyman, co-founder of Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Google DeepMind, as the CEO of a new consumer AI division in March. This division oversees projects such as Copilot, Bing, and Edge. 
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38362859/microsoft-in-unique-position-to-scale-gen-ai-revenue-goldman-sachs-says-ahead-of-q3">Microsoft &#8216;In Unique Position To Scale Gen-AI Revenue,&#8217; Goldman Sachs Says Ahead Of Q3 Earnings</a>
Photo: <a href="https://www.shutterstock.com/es/g/inbj">IB Photography</a> on Shutterstock.

Management

Tech

GOOG

GOOGL

MSFT

Microsoft Boosts AI Arsenal With Former Meta Executive Jason Taylor

SAIA

Saia LTL Freight Plans To Open Two New Terminals, One Near Trenton, New Jersey, And Another In St. George, Utah

Lufax Says David Siu Kam Choy Has Tendered His Resignation As CFO Due To Personal Reasons; Peiqing Zhu Appointed As New CFO And Board Secretary, Effective On April 30, 2024

ata from 10 abstracts, including six oral presentations, provide insight on Regeneron&#39;s approach to overcoming obstacles to clinical implementation of genetic medicines, from pre-dosing to delivery to long-term sustained expression. The company will also present updated data from the Phase 1/2 CHORD trial investigating DB-OTO in children with profound genetic hearing loss due to mutations of the otoferlin gene.

REGN

Regeneron To Present New And Updated Data Across Its Genetic Medicines Portfolio At ASGCT Annual Conference

Based on initial targeted data sampling to date, the company has found files containing protected health information (PHI) or personally identifiable information (PII), which could cover a substantial proportion of people in America. To date, the company has not seen evidence of exfiltration of materials such as doctors&#39; charts or full medical histories among the data.
Change Healthcare has made continued strong progress restoring services impacted by the event.&nbsp;Pharmacy services are now back to near-normal levels, with&nbsp;99%&nbsp;of pre-incident pharmacies able to process claims.

UnitedHealth Provides Update On Change Healthcare Cyberattack; Reveals Progress In Restoring Change Healthcare Services

Beverage and food giant PepsiCo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) is set to report first-quarter financial results before the market open <a href="https://www.benzinga.com/calendars/earnings">Tuesday.</a>
Here are the key earnings estimates and what analysts are saying ahead of the report.
Earnings Estimates: Analysts expect Pepsi to report first-quarter revenue of $18.08 billion, according to <a href="https://pro.benzinga.com/feature/newsfeed/?gspk=bHVrZWphY29iaTUzNDg&amp;gsxid=tdEE0VrK8Jeg&amp;ref=lukejacobi5348">estimates from Benzinga Pro.</a>
The company reported revenue of $17.85 billion in last year's first quarter. Pepsi beat revenue estimates from analysts in nine of the past 10 quarters.
Analysts expect Pepsi to report first-quarter earnings per share of $1.52, compared to $1.50 reported in last year's first quarter. The company beat Street consensus estimates in 10 of the past 10 quarters.
Related Link: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38360223/pepsi-stock-chart-looks-bullish-ahead-of-q1-ratings-but-analysts-are-cautious">Pepsi Stock Chart Looks Bullish Ahead Of Q1 Earnings, But Analysts Are Cautious</a>
What Analysts Are Saying: A Quaker recall and slowdown of salty snacks could impact the first quarter results from Pepsi, Wedbush analyst Gerald Pascarelli said in a new investor note.
"Based on measured channel reads, we are modestly trimming our 1Q revenue estimate for PEP due to a larger than expected slowdown in salty snacks," Pascarelli said.
The analyst, who has an Outperform rating and $195 price target, said the company could start 2024 with trends behind guidance for the full year.
"With international expected to continue to outperform domestic markets, we think the quarter should be fine and that PEP will reiterate its current organic sales and LC EPS guidance."
Here are other recent<a href="https://www.benzinga.com/quote/PEP/analyst-ratings"> analyst ratings </a>and price targets on Pepsi.
Barclays: Overweight rating, raised price target from $183 to $184
Jefferies: Buy rating, raised price target from $199 to $209
Morgan Stanley: Upgraded from Equal Weight to Overweight, had $190 price target
PEP Price Action: Pepsi shares were up 1.34% to $176.46 at market close Monday versus a 52-week trading range of $155.83 to $196.88. Shares of Pepsi are up 4% year-to-date in 2024.
Read Next: <a href="https://www.benzinga.com/news/24/04/38142749/food-giants-pivot-to-discounts-and-new-sizes-amid-decreased-spending-by-low-income-americans">Food Giants Pivot To Discounts And New Sizes Amid Decreased Spending by Low-Income Americans</a>
Photo: <a href="https://www.shutterstock.com/g/rafapress">rafapress</a> via Shutterstock

Earnings

PepsiCo Q1 Earnings Preview: Can Beverage Giant Keep Streak Of EPS Beats Alive? One Analyst Cautions On Salty Snacks

Contracts

Overseas Shipholding Secures $3M Grant From US Department Of Energy For Engineering And Design Of New Vessel That Will Transport Liquified Carbon Dioxide

GBIO

Generation Bio Reports Acceptance Of Five Abstracts And An Invited Oral Presentation At ASGCT 27th Annual Meeting

Lufax Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LU#NYSE">LU</a>) reported quarterly losses of $(0.21) per share. The company reported quarterly sales of $964.000 million which missed the analyst consensus estimate of $1.035 billion by 6.85 percent. This is a 34.29 percent decrease over sales of $1.467 billion the same period last year.

Lufax Holding Q1 2024 GAAP Loss Per ADS $(0.21), Sales $964.000M Miss $1.035B Estimate

Editor&#8217;s note: This story has been corrected to reflect that Boeing reports earnings premarket Wednesday.
As the market awaits Boeing Co's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) earnings call this week, investors are wondering whether the company's results will be strong enough to counter <a href="https://www.benzinga.com/news/24/03/37580235/boeing-faces-enormous-scrutiny-after-recent-mishaps-report">recent scandals hunting the company's public image</a>.
The aircraft manufacturer will release its results premarket Wednesday.
Boeing is facing major criticism over safety concerns that sprouted several federal investigations and are eroding investor trust in the company.
Boeing has become among the most volatile stocks in the aerospace and defense sector, with its shares dropping 32.5% since January, after an aircraft made by the company lost a part of its fuselage.&nbsp;
Before the drop, Boeing's stock grew around 47% between late October and mid-December.
By contrast, iShares US Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>), the largest ETF in the sector by total assets, is up 2.3% since January and 11% in the past year. About 13% of the fund's assets consist of Boeing stock.
Invesco Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPA#NYSE">PPA</a>), which has 6% of its assets allocated to Boeing, has performed even better, and is up 8.7% since January and 22% in the past year.
Airbus SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/EADSY#OTC">EADSY</a>), Boeing's main competitor in the commercial aviation market, has benefited from Boeing's downfall, and its shares are up 12% since January and 22% in the past year.
Read also: <a href="https://www.benzinga.com//node/38330397">Boeing Wants To Make Flying Cars In Asia While Aircraft Unit Faces Severe Turbulence</a>
<h3 class="wp-block-heading">Analysts Weigh In On Boeing</h3>
On Monday, Barclays analyst David Strauss maintained Boeing's rating (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with an Equal-Weight but lowered the company's price target from $235 to $190.
According to a Zacks analysis, the recent increase in research and development expenses and a decrease in aircraft deliveries are likely to negatively impact the company&#8217;s performance in the upcoming earnings call.
The company sold 40% fewer 737 planes than the same period last year. Overall, commercial airplane sales were down by 36.2%.
However, stronger sales in the 767 and 787 segments, which generate more revenue per plane, could offset the 737 slump.
Consensus earnings per share forecast for Q1, ahead of the report, is $-1.43, according to Zacks, based on nine analysts&#8217; forecasts. EPS for the same quarter last year was $-1.27.
<h3 class="wp-block-heading">Boeing's Legal Woes, Safety Scandals During 2024</h3>
Boeing's recent history has been plagued with controversies which include several federal probes, the resignation of its CEO and the suspicious death of a whistleblower.
The company has been subject to at least <a href="https://www.benzinga.com/markets/equities/24/04/38330613/boeing-grapples-with-32-whistleblower-complaints-in-3-years-amid-mounting-safety-concerns-report">32 whistleblower complaints in the past three years</a>.
In January, a Boeing 737 Max 9 flown by Alaska Air Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) <a href="https://www.benzinga.com/markets/equities/24/01/36523143/im-going-to-die-passengers-experience-15-minute-nightmare-during-alaska-airs-harrowing-emergency">lost an emergency door mid-flight</a>, terrifying passengers and sparking widespread concerns about the company's responsibility for the incident.
The Department of Justice launched a criminal investigation and <a href="https://www.benzinga.com/news/24/03/37580235/boeing-faces-enormous-scrutiny-after-recent-mishaps-report">the company is facing lawsuits</a> from several passengers on the flight.
The event was a blow to the company's 737 Max line, which had already faced severe actions from the FAA after two 737 Max 8 aircraft crashed in similar conditions during 2018 and 2019, costing 346 lives.
The incident triggered a domino effect that damaged the company's public image in the following months.
737 Max 9 planes were blocked from flying by the FAA for about two weeks until the agency allowed them to get back in the air. FAA Administrator Mike Whitaker however, said &#8220;this won&#8217;t be back to business as usual for Boeing.&#8221;&nbsp;
The turbulence continued into March when the FAA&#8217;s audit found the company deficient in<a href="http://benzinga.com/markets/equities/24/03/37638308/boeing-shares-tumble-after-faa-investigation-fails-33-out-of-89-audits"> 33 of 89 review points.</a>
Ed Clark, the head of the company's 737 Max division resigned, which was followed by the announcement that the company's CEO Dave Calhoun will leave his post<a href="https://www.benzinga.com/news/large-cap/24/03/37911999/boeing-ceo-dave-calhoun-to-resign-in-2024-as-part-of-major-leadership-overhaul-eyes-of-the-world-a"> by the end of the year</a>.
Last month, John Barnett, a former Boeing employee who raised safety concerns after being at the company for over 32 years, was found dead in a hotel room<a href="https://www.benzinga.com/news/24/03/37605536/former-boeing-employee-who-raised-safety-concerns-found-dead-amid-companys-legal-turmoil"> from self-inflicted wounds</a>. Barnett had testified as a witness against Boeing and was set to return to court days after his death.
In parallel to the FAA's audit, the National Transportation Safety Board has announced a public hearing into the company, which will be conducted in August.
<h3 class="wp-block-heading">Boeing Could Get Into Even More Trouble With DOJ&nbsp;</h3>
Last week, a Senate committee held a hearing which<a href="https://www.benzinga.com/markets/equities/24/04/38307060/everybody-wants-boeing-to-succeed-gop-senator-stresses-safety-in-the-skies-post-whistleblower-te"> examined Boeing's safety issues</a>. Sen. Ron Johnson (R-WI) said, "everybody wants Boeing to succeed."
The committee brought back into the spotlight a deal the company reached with the Department of Justice in 2021, on several charges of fraud. After the crashes of 2018 and 2019, Boeing admitted having withheld critical information about technical aspects of its aircraft.
This led to a deal that had Boeing pay $2.5 billion in penalties. Now, senators say the company could have broken the terms of the deal after the NTSB failed to receive key documentation from Boeing on the construction of the aircraft that failed in January.
A DOJ probe is currently investigating whether the deal was broken. If Boeing is found guilty, the department could impose further fines, and potentially affect the company's ability to land new contracts with the U.S. government, according to Reuters.
Now read: <a href="https://www.benzinga.com//node/38297698">Boeing Heads To Space: Could NASA Deal, Starliner Help Fend Off Airplane Segment Weakness?</a>
Shutterstock image.

Downgrades

Travel

European Aeronautic Defence And Space Unsponsored

EADSY

iShares Dow Jones US Aerospace & Defense Index Fund

Boeing Will Deliver Q1 Earnings While At Center Of Air Safety Scandal: 'Everybody Wants Boeing To Succeed' (CORRECTED)

In its upcoming report, Astrazeneca (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/azn#NYSE">AZN</a>) is predicted by Wall Street analysts to post quarterly earnings of $0.95 per share, reflecting a decline of 1% compared to the same period last year. Revenues are forecasted to be $11.94 billion, representing a year-over-year increase of 9.7%.
Over the last 30 days, there has been a downward revision of 1.7% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts&#39; collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company&#39;s earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts&#39; forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let&#39;s delve into the average estimates of some Astrazeneca metrics that Wall Street analysts commonly model and monitor.
The collective assessment of analysts points to an estimated &#39;Product Sales- CVRM- Brilinta&#39; of $310.25 million. The estimate indicates a year-over-year change of -7.1%.
The consensus among analysts is that &#39;Product Sales- CVRM- Onglyza&#39; will reach $49.01 million. The estimate indicates a change of -22.2% from the prior-year quarter.
Analysts predict that the &#39;Product Sales- CVRM- Farxiga&#39; will reach $1.62 billion. The estimate points to a change of +24.9% from the year-ago quarter.
The average prediction of analysts places &#39;Product Sales- Oncology- Lynparza&#39; at $724.52 million. The estimate indicates a change of +11.3% from the prior-year quarter.
According to the collective judgment of analysts, &#39;Fasenra- U.S. Sales&#39; should come in at $227.69 million. The estimate indicates a year-over-year change of +13.3%.
The combined assessment of analysts suggests that &#39;Brilinta- U.S. Sales&#39; will likely reach $167.43 million. The estimate points to a change of -6.5% from the year-ago quarter.
It is projected by analysts that the &#39;Onglyza- U.S. Sales&#39; will reach $6.32 million. The estimate indicates a change of -54.8% from the prior-year quarter.
Analysts expect &#39;Lynparza- U.S. Sales&#39; to come in at $302.51 million. The estimate indicates a change of +12.9% from the prior-year quarter.
The consensus estimate for &#39;Imfinzi- U.S. Sales&#39; stands at $635.60 million. The estimate suggests a change of +21.8% year over year.
Analysts&#39; assessment points toward &#39;Calquence- U.S. Sales&#39; reaching $442.60 million. The estimate indicates a change of +15.3% from the prior-year quarter.
Analysts forecast &#39;Farxiga- U.S. Sales&#39; to reach $400.36 million. The estimate indicates a change of +35.3% from the prior-year quarter.
Based on the collective assessment of analysts, &#39;Lokelma- U.S. Sales&#39; should arrive at $64.23 million. The estimate indicates a change of +14.7% from the prior-year quarter. 
Over the past month, Astrazeneca shares have recorded returns of +3.5% versus the Zacks S&amp;P 500 composite&#39;s -4% change. Based on its Zacks Rank #3 (Hold), AZN will likely exhibit a performance that aligns with the overall market in the upcoming period.
<a href="https://www.zacks.com/stock/news/2259072/insights-into-astrazeneca-azn-q1-wall-street-projections-for-key-metrics?cid=CS-BENZ-FT-fundamental_analysis|nfm_preview-2259072">To read this article on Zacks.com click here.</a>

Insights Into Astrazeneca Q1: Wall Street Projections for Key Metrics

Wall Street analysts expect Intel (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>) to post quarterly earnings of $0.13 per share in its upcoming report, which indicates a year-over-year increase of 425%. Revenues are expected to be $12.76 billion, up 8.9% from the year-ago quarter.
Over the last 30 days, there has been a downward revision of 5.8% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts&#39; collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company&#39;s earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts&#39; projections for specific key metrics can offer valuable insights.
In light of this perspective, let&#39;s dive into the average estimates of certain Intel metrics that are commonly tracked and forecasted by Wall Street analysts.
The average prediction of analysts places &#39;Net Revenues- Data Center and AI&#39; at $3.31 billion. The estimate suggests a change of -11.1% year over year.
The consensus among analysts is that &#39;Net Revenues- Client Computing Group&#39; will reach $7.28 billion. The estimate indicates a change of +26.3% from the prior-year quarter.
According to the collective judgment of analysts, &#39;Net Revenues- Network and Edge&#39; should come in at $1.31 billion. The estimate suggests a change of -64.7% year over year.
Analysts&#39; assessment points toward &#39;Net Revenues- Mobileye&#39; reaching $280.30 million. The estimate points to a change of -38.8% from the year-ago quarter.
Analysts forecast &#39;Net Revenues- Client Computing- Notebook&#39; to reach $4.15 billion. The estimate suggests a change of +21.8% year over year.
Based on the collective assessment of analysts, &#39;Net Revenues- Intel Foundry Services&#39; should arrive at $4.22 billion. The estimate indicates a change of +3479% from the prior-year quarter.
It is projected by analysts that the &#39;Net Revenues- Client Computing- Desktop&#39; will reach $2.63 billion. The estimate indicates a year-over-year change of +40.1%. 
Over the past month, Intel shares have recorded returns of -19.7% versus the Zacks S&amp;P 500 composite&#39;s -4% change. Based on its Zacks Rank #3 (Hold), INTC will likely exhibit a performance that aligns with the overall market in the upcoming period.&nbsp;
<a href="https://www.zacks.com/stock/news/2259080/intel-intc-q1-earnings-preview-what-you-should-know-beyond-the-headline-estimates?cid=CS-BENZ-FT-fundamental_analysis|nfm_preview-2259080">To read this article on Zacks.com click here.</a>

INTC

Intel Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Wall Street analysts forecast that Caterpillar (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cat#NYSE">CAT</a>) will report quarterly earnings of $5.14 per share in its upcoming release, pointing to a year-over-year increase of 4.7%. It is anticipated that revenues will amount to $16.06 billion, exhibiting an increase of 1.3% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.6% to its current level. This demonstrates the covering analysts&#39; collective reassessment of their initial projections during this period.
Prior to a company&#39;s earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts&#39; projections for some of the company&#39;s key metrics often helps gain a deeper insight.
With that in mind, let&#39;s delve into the average projections of some Caterpillar metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus among analysts is that &#39;Total sales and revenues- Financial Products- Total&#39; will reach $816.70 million. The estimate suggests a change of +7% year over year.
The consensus estimate for &#39;Total sales and revenues- Machinery, Energy &amp; Transportation- Resource Industries&#39; stands at $3.29 billion. The estimate indicates a year-over-year change of -4%.
Analysts forecast &#39;Total sales and revenues- Machinery, Energy &amp; Transportation- Energy &amp; Transportation&#39; to reach $6.34 billion. The estimate suggests a change of +1.4% year over year.
Analysts expect &#39;Total sales and revenues- Machinery, Energy &amp; Transportation- All Other&#39; to come in at $120.59 million. The estimate indicates a change of +8.6% from the prior-year quarter.
According to the collective judgment of analysts, &#39;Sales and Revenues- Asia/Pacific- Machinery, Energy &amp; Transportation- All Other Segments&#39; should come in at $13.18 million. The estimate indicates a year-over-year change of +1.4%.
Analysts&#39; assessment points toward &#39;Sales and Revenues- North America- Machinery, Energy &amp; Transportation- Construction&#39; reaching $3.70 billion. The estimate suggests a change of +2.5% year over year.
The collective assessment of analysts points to an estimated &#39;Sales and Revenues- North America- Machinery, Energy &amp; Transportation- Resource Industries&#39; of $1.25 billion. The estimate indicates a year-over-year change of -4.7%.
The average prediction of analysts places &#39;Sales and Revenues- North America- Machinery, Energy &amp; Transportation- Energy &amp; Transportation&#39; at $2.76 billion. The estimate points to a change of +7.2% from the year-ago quarter.
It is projected by analysts that the &#39;Sales and Revenues- North America- Machinery, Energy &amp; Transportation- All Other Segments&#39; will reach $17.91 million. The estimate indicates a year-over-year change of -0.5%.
Analysts predict that the &#39;Sales and Revenues- Latin America- Machinery, Energy &amp; Transportation- Construction&#39; will reach $587.04 million. The estimate indicates a year-over-year change of -2%.
The combined assessment of analysts suggests that &#39;Sales and Revenues- Latin America- Machinery, Energy &amp; Transportation- Resource Industries&#39; will likely reach $479.41 million. The estimate suggests a change of +1.1% year over year.
Based on the collective assessment of analysts, &#39;Sales and Revenues- Latin America- Machinery, Energy &amp; Transportation- Energy &amp; Transportation&#39; should arrive at $411.79 million. The estimate indicates a change of +8.4% from the prior-year quarter. 
Shares of Caterpillar have experienced a change of -1% in the past month compared to the -4% move of the Zacks S&amp;P 500 composite. With a Zacks Rank #3 (Hold), CAT is expected to mirror the overall market performance in the near future.
<a href="https://www.zacks.com/stock/news/2259093/exploring-analyst-estimates-for-caterpillar-cat-q1-earnings-beyond-revenue-and-eps?cid=CS-BENZ-FT-fundamental_analysis|nfm_preview-2259093">To read this article on Zacks.com click here.</a>

Exploring Analyst Estimates for Caterpillar Q1 Earnings, Beyond Revenue and EPS

The upcoming report from Alphabet (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) is expected to reveal quarterly earnings of $1.49 per share, indicating an increase of 27.4% compared to the year-ago period. Analysts forecast revenues of $66.02 billion, representing an increase of 13.7% year over year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company&#39;s earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts&#39; projections for specific key metrics can offer valuable insights.
Given this perspective, it&#39;s time to examine the average forecasts of specific Alphabet metrics that are routinely monitored and predicted by Wall Street analysts.
The combined assessment of analysts suggests that &#39;Revenues- Google properties&#39; will likely reach $52.44 billion. The estimate indicates a change of +11.4% from the prior-year quarter.
According to the collective judgment of analysts, &#39;Revenues- Google Cloud&#39; should come in at $9.25 billion. The estimate suggests a change of +24.1% year over year.
The consensus estimate for &#39;Revenues- YouTube ads&#39; stands at $7.71 billion. The estimate suggests a change of +15.1% year over year.
Analysts&#39; assessment points toward &#39;Revenues- Google advertising&#39; reaching $60.18 billion. The estimate points to a change of +10.3% from the year-ago quarter.
Analysts forecast &#39;Revenues- Google Search &amp; other&#39; to reach $44.73 billion. The estimate suggests a change of +10.8% year over year.
Analysts expect &#39;Revenues- Google Network&#39; to come in at $7.67 billion. The estimate indicates a change of +2.3% from the prior-year quarter.
Analysts predict that the &#39;Revenues- EMEA&#39; will reach $23.40 billion. The estimate suggests a change of +11% year over year.
The collective assessment of analysts points to an estimated &#39;Revenues- United States&#39; of $36.99 billion. The estimate suggests a change of +12.6% year over year.
Based on the collective assessment of analysts, &#39;Revenues- Other Americas&#39; should arrive at $4.47 billion. The estimate indicates a change of +9.7% from the prior-year quarter.
It is projected by analysts that the &#39;Revenues- APAC&#39; will reach $13.46 billion. The estimate indicates a change of +15.3% from the prior-year quarter.
The consensus among analysts is that &#39;Total TAC (traffic acquisition costs)&#39; will reach $12.67 billion. Compared to the present estimate, the company reported $11.72 billion in the same quarter last year.
The average prediction of analysts places &#39;Headcount (Number of employees)&#39; at 181,850. Compared to the current estimate, the company reported 190,711 in the same quarter of the previous year. 
Shares of Alphabet have experienced a change of +2.2% in the past month compared to the -4% move of the Zacks S&amp;P 500 composite. With a Zacks Rank #3 (Hold), GOOGL is expected to mirror the overall market performance in the near future.
<a href="https://www.zacks.com/stock/news/2259106/exploring-analyst-estimates-for-alphabet-googl-q1-earnings-beyond-revenue-and-eps?cid=CS-BENZ-FT-fundamental_analysis|nfm_preview-2259106">To read this article on Zacks.com click here.</a>

Exploring Analyst Estimates for Alphabet Q1 Earnings, Beyond Revenue and EPS

In its upcoming report, American Airlines (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aal#NASDAQ">AAL</a>) is predicted by Wall Street analysts to post quarterly loss of $0.28 per share, reflecting a decline of 660% compared to the same period last year. Revenues are forecasted to be $12.59 billion, representing a year-over-year increase of 3.3%.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2% to its current level. This demonstrates the covering analysts&#39; collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it&#39;s common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts&#39; forecasts for key metrics can yield valuable insights.
Given this perspective, it&#39;s time to examine the average forecasts of specific American Airlines metrics that are routinely monitored and predicted by Wall Street analysts.
Based on the collective assessment of analysts, &#39;Revenue- Passenger&#39; should arrive at $11.48 billion. The estimate indicates a change of +3.4% from the prior-year quarter.
According to the collective judgment of analysts, &#39;Revenue- Other&#39; should come in at $890.29 million. The estimate points to a change of +3.2% from the year-ago quarter.
The combined assessment of analysts suggests that &#39;Revenue- Cargo&#39; will likely reach $197.34 million. The estimate points to a change of -11.5% from the year-ago quarter.
It is projected by analysts that the &#39;Operating cost per ASM excluding net special items and fuel - Total&#39; will reach 13.52 cents. Compared to the current estimate, the company reported 13.18 cents in the same quarter of the previous year.
The average prediction of analysts places &#39;Operating cost per ASM excluding net special items - Total&#39; at 17.78 cents. Compared to the present estimate, the company reported 18.06 cents in the same quarter last year.
Analysts forecast &#39;Passenger load factor (percent) - Total&#39; to reach 82.0%. Compared to the current estimate, the company reported 80% in the same quarter of the previous year.
Analysts predict that the &#39;Average aircraft fuel price including related taxes - Total&#39; will reach $2.8 per gallon. Compared to the present estimate, the company reported 3.28 $/gal in the same quarter last year.
The consensus estimate for &#39;Passenger revenue per ASM - Total&#39; stands at 16.44 cents. The estimate is in contrast to the year-ago figure of 17.08 cents.
Analysts&#39; assessment points toward &#39;Total revenue per ASM - Total&#39; reaching 17.97 cents. The estimate is in contrast to the year-ago figure of 18.75 cents.
Analysts expect &#39;Available seat miles - Total&#39; to come in at 69,868.31 million. Compared to the current estimate, the company reported 65,006 million in the same quarter of the previous year.
The consensus among analysts is that &#39;Yield - Total&#39; will reach 19.85 cents. The estimate compares to the year-ago value of 21.35 cents.
The collective assessment of analysts points to an estimated &#39;Fuel consumption - Total&#39; of 1,052.37 MGal. The estimate compares to the year-ago value of 965 MGal. 
American Airlines shares have witnessed a change of -4.8% in the past month, in contrast to the Zacks S&amp;P 500 composite&#39;s -4% move. With a Zacks Rank #3 (Hold), AAL is expected closely follow the overall market performance in the near term.
<a href="https://www.zacks.com/stock/news/2259111/american-airlines-aal-q1-earnings-on-the-horizon-analysts-insights-on-key-performance-measures?cid=CS-BENZ-FT-fundamental_analysis|nfm_preview-2259111">To read this article on Zacks.com click here.</a>

American Airlines Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

In its upcoming report, Royal Caribbean (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rcl#NYSE">RCL</a>) is predicted by Wall Street analysts to post quarterly earnings of $1.30 per share, reflecting an increase of 665.2% compared to the same period last year. Revenues are forecasted to be $3.64 billion, representing a year-over-year increase of 26.3%.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts&#39; collective reassessment of their initial projections during this period.
Prior to a company&#39;s earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts&#39; projections for specific key metrics can offer valuable insights.
In light of this perspective, let&#39;s dive into the average estimates of certain Royal Caribbean metrics that are commonly tracked and forecasted by Wall Street analysts.
According to the collective judgment of analysts, &#39;Revenues- Onboard and other&#39; should come in at $1.18 billion. The estimate suggests a change of +19.8% year over year.
The consensus among analysts is that &#39;Revenues- Passenger ticket&#39; will reach $2.45 billion. The estimate suggests a change of +29.4% year over year.
The collective assessment of analysts points to an estimated &#39;APCD (Available passenger cruise days)&#39; of 12,311.44 Days. Compared to the current estimate, the company reported 11,233.49 Days in the same quarter of the previous year.
Analysts&#39; assessment points toward &#39;Occupancy Rate&#39; reaching 106.6%. Compared to the present estimate, the company reported 102.1% in the same quarter last year.
Analysts predict that the &#39;Passenger Cruise Days&#39; will reach 13,130.53 Days. Compared to the present estimate, the company reported 11,474.74 Days in the same quarter last year.
Based on the collective assessment of analysts, &#39;Net Cruise Costs Excluding Fuel per APCD&#39; should arrive at $133.63. The estimate is in contrast to the year-ago figure of $124.70.
Analysts expect &#39;Net Cruise Costs per APCD&#39; to come in at $158.61. Compared to the present estimate, the company reported $151.54 in the same quarter last year.
Analysts forecast &#39;Passengers Carried&#39; to reach 2,053.82 thousand. The estimate is in contrast to the year-ago figure of 1,806.27 thousand. 
Over the past month, shares of Royal Caribbean have returned -5% versus the Zacks S&amp;P 500 composite&#39;s -4% change. Currently, RCL carries a Zacks Rank #2 (Buy), suggesting that it may outperform the overall market in the near future.
<a href="https://www.zacks.com/stock/news/2259124/insights-into-royal-caribbean-rcl-q1-wall-street-projections-for-key-metrics?cid=CS-BENZ-FT-fundamental_analysis|nfm_preview-2259124">To read this article on Zacks.com click here.</a>